AR248402A1 - Procedimiento para la preparacion de 4-/3-(4-oxotiazoldinil)/butinilaminas utiles como medicamentos. - Google Patents

Procedimiento para la preparacion de 4-/3-(4-oxotiazoldinil)/butinilaminas utiles como medicamentos.

Info

Publication number
AR248402A1
AR248402A1 AR91319454A AR31945491A AR248402A1 AR 248402 A1 AR248402 A1 AR 248402A1 AR 91319454 A AR91319454 A AR 91319454A AR 31945491 A AR31945491 A AR 31945491A AR 248402 A1 AR248402 A1 AR 248402A1
Authority
AR
Argentina
Prior art keywords
preparation
alkyl
oxothiazoldinyl
butynylamines
medicaments
Prior art date
Application number
AR91319454A
Other languages
English (en)
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of AR248402A1 publication Critical patent/AR248402A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO DE FORMULA (I) DONDE R1 Y R2 SON, H O ALQUILO O R1 Y R2 JUNTOS FORMAN UN CICLOALCANO; R3 Y R4 SON H O ALQUILO, O R3 Y R4 JUNTOS FORMAN UN CICLOALCANO; R5 Y R6 JUNTOS SON: PIPERIDINIO 4-SUSTITUIDO POR FENILO; FENIL CARBONILO, FENILOXI O PIPERAZINIO SUSTITUIDO EN EL N POR FENILO O ALQUILFENILO SUSTITUIDO A SU VEZ POR (X)M O LAS FORMULAS A, B, C, D, DONDE X ES HALOGENO, ALQUILO, HIDROXI, NITRO, AMINO, CIANO, TRIFLUORMETILO O METOXI; Y M ES 0, 1 O 2; DONDE SE HACE REACCIONAR UN COMPUESTO DE FORMULA (II) CON FORMALDEHIDO, CON UNA AMINA CONVENIENTE EN PRESENCIA DE UN CATALIZADOR.
AR91319454A 1990-04-16 1991-04-12 Procedimiento para la preparacion de 4-/3-(4-oxotiazoldinil)/butinilaminas utiles como medicamentos. AR248402A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/509,280 US5034392A (en) 1990-04-16 1990-04-16 4-(3-(4-oxothiazolidinyl)butynylamines

Publications (1)

Publication Number Publication Date
AR248402A1 true AR248402A1 (es) 1995-08-18

Family

ID=24025983

Family Applications (1)

Application Number Title Priority Date Filing Date
AR91319454A AR248402A1 (es) 1990-04-16 1991-04-12 Procedimiento para la preparacion de 4-/3-(4-oxotiazoldinil)/butinilaminas utiles como medicamentos.

Country Status (26)

Country Link
US (1) US5034392A (es)
EP (1) EP0452850B1 (es)
JP (1) JPH07119223B2 (es)
KR (1) KR0163598B1 (es)
AR (1) AR248402A1 (es)
AT (1) ATE163010T1 (es)
AU (1) AU636972B2 (es)
BG (1) BG60066A3 (es)
CA (1) CA2040489C (es)
CZ (1) CZ284447B6 (es)
DE (1) DE69128845T2 (es)
DK (1) DK0452850T3 (es)
ES (1) ES2112844T3 (es)
FI (1) FI94755C (es)
GR (1) GR3026319T3 (es)
HU (1) HUT61017A (es)
IE (1) IE911257A1 (es)
IL (1) IL97852A (es)
MX (1) MX25359A (es)
NO (1) NO300134B1 (es)
NZ (1) NZ237811A (es)
PL (1) PL165488B1 (es)
PT (1) PT97371B (es)
RO (1) RO108683B1 (es)
RU (1) RU2001914C1 (es)
ZA (1) ZA912783B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273977A (en) * 1990-11-05 1993-12-28 Warner-Lambert Company Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
US5194436A (en) * 1991-01-10 1993-03-16 Hoechst-Roussel Pharmaceuticals Inc. 1-piperazinyl-2-butenes and -2-butynes
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354178A (en) * 1965-04-09 1967-11-21 Sterling Drug Inc Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides
EP0316723B1 (en) * 1987-11-20 1992-09-30 Hoechst-Roussel Pharmaceuticals Incorporated 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
PL165488B1 (pl) 1994-12-30
JPH07119223B2 (ja) 1995-12-20
DK0452850T3 (da) 1998-09-23
BG60066A3 (en) 1993-09-15
ZA912783B (en) 1991-12-24
FI911783A0 (fi) 1991-04-12
DE69128845D1 (de) 1998-03-12
PT97371B (pt) 1998-08-31
US5034392A (en) 1991-07-23
ATE163010T1 (de) 1998-02-15
FI911783A (fi) 1991-10-17
CZ284447B6 (cs) 1998-11-11
PL289892A1 (en) 1992-07-27
IL97852A (en) 1994-11-28
AU7502891A (en) 1991-10-17
IL97852A0 (en) 1992-06-21
FI94755B (fi) 1995-07-14
AU636972B2 (en) 1993-05-13
MX25359A (es) 1994-05-31
CA2040489A1 (en) 1991-10-17
RU2001914C1 (ru) 1993-10-30
FI94755C (fi) 1995-10-25
JPH04234879A (ja) 1992-08-24
NO911465L (no) 1991-10-17
PT97371A (pt) 1992-01-31
NO911465D0 (no) 1991-04-15
EP0452850B1 (en) 1998-02-04
NZ237811A (en) 1993-12-23
KR0163598B1 (ko) 1998-12-01
HUT61017A (en) 1992-11-30
KR910018367A (ko) 1991-11-30
DE69128845T2 (de) 1998-07-09
CS9101065A2 (en) 1991-11-12
IE911257A1 (en) 1991-10-23
HU911239D0 (en) 1991-10-28
RO108683B1 (ro) 1994-07-29
ES2112844T3 (es) 1998-04-16
NO300134B1 (no) 1997-04-14
CA2040489C (en) 2003-06-10
EP0452850A1 (en) 1991-10-23
GR3026319T3 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
DE69530094D1 (de) Thiazolidindione derivate, ihre herstellung und verwendung
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
CO4410319A1 (es) Derivados de fenetanolamina
PT87578A (pt) Process for the preparation of new alkanesulfonanilide derivatives and of pharmaceutical composition comprising the same
AR248402A1 (es) Procedimiento para la preparacion de 4-/3-(4-oxotiazoldinil)/butinilaminas utiles como medicamentos.
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
FI881104A (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
DK0728138T3 (da) Anthracyclinderivater
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
DE69132578T2 (de) Cephemderivate
ATE27452T1 (de) Substituierte o-phenylendiaminderivate.
SE7609909L (sv) Nya penicilliner och forfarande for framstellning derav
BR9801448B1 (pt) compostos heterocÍclicos, processo para sua preparaÇço e composiÇÕes farmacÊuticas contendo os mesmos.
FI904512A0 (fi) Menetelmä lääkeaineina käytettävien 1,3-tiatsolidinien -karbonyylikarboksiamidien valmistamiseksi
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
ES2089097T3 (es) Procedimiento para la fabricacion de derivados de bencilftalacinona y sales de la misma.
AR247882A1 (es) Derivados de pirimidina, procedimientos para su preparacion, agentes que los contienen y su utilizacion como fungicidas
FI821944A0 (fi) Tricykliska foereningar
DE3679257D1 (de) 4-cyanopiperidine-derivate, herstellung und anwendung.
AR247563A1 (es) Nuevos derivados de piridinilpirimidina y un protector para enfermedades de las plantas que los contienen como ingrediente activo
ES2059928T3 (es) Ciclopropanotiocarboxiamidas.